Our findings also show that CSF selenoprotein P concentrations tend to linearly correlate with biomarkers of neurodegeneration in AD but not in MCI and have a considerably more linear, monotonic pattern of association with both ALS and AD risk as compared with the blood concentrations of this protein. The gene discussed is SELENOP; the disease is amyotrophic lateral sclerosis.